-
1
المؤلفون: Cheryl Enger, Libby Horter, Nina Sahlertz Kristiansen, Stefan de Vogel, Kelesitse Phiri, Brandon T. Suehs, Jesper Hallas, Alejandro Arana, Marie Linder, Ingvild Odsbu, Yihua Xu, Andrea V. Margulis, Kwame Appenteng, John D. Seeger, Morten Olesen, Veena Hoffman, Susana Perez-Gutthann
المصدر: Hoffman, V, Hallas, J, Linder, M, Margulis, A, Suehs, B T, Arana, A, Phiri, K, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Xu, Y, Kristiansen, N S, Appenteng, K, de Vogel, S, Seeger, J D & the mirabegron PMR-PASS study group 2021, ' Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder : Findings from a Non-Interventional, Multinational, Cohort Study ', Drug Safety, vol. 44, no. 8, pp. 899-915 . https://doi.org/10.1007/s40264-021-01095-7Test
Drug Safetyمصطلحات موضوعية: Male, medicine.medical_specialty, Population, Muscarinic Antagonists, Toxicology, Cohort Studies, Risk Factors, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, education, Stroke, Aged, Pharmacology, education.field_of_study, Proportional hazards model, business.industry, Urinary Bladder, Overactive, Hazard ratio, medicine.disease, Thiazoles, Treatment Outcome, Overactive bladder, Cardiovascular Diseases, Heart Disease Risk Factors, Acetanilides, Female, Treatments for overactive bladder, Mirabegron, business, medicine.drug, Cohort study
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606ed98949016a3becf28423411ba054Test
https://findresearcher.sdu.dk:8443/ws/files/191412893/Hoffman2021_Article_CardiovascularRiskInUsersOfMir.pdfTest -
2
المصدر: Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacologyمصطلحات موضوعية: Cannabinoid receptor, Mini Review, Central nervous system, 030232 urology & nephrology, bladder dysfunction, Sensory system, RM1-950, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, medicine, Cannabinoid receptor type 2, Pharmacology (medical), Urothelium, endocannabinoids, Pharmacology, business.industry, medicine.disease, Endocannabinoid system, bladder afferents, medicine.anatomical_structure, Overactive bladder, painful bladder syndrome, lipids (amino acids, peptides, and proteins), overactive bladder, Therapeutics. Pharmacology, Treatments for overactive bladder, business, Neuroscience, 030217 neurology & neurosurgery
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e83d580f9ae5a1c3d48963f3097a09a8Test
-
3
المؤلفون: John D. Seeger, Marie Linder, Veena Hoffman, Alejandro Arana, Shahram Bahmanyar, Susana Perez-Gutthann, Jesper Hallas, Libby Horter, Brandon T. Suehs, Stefan de Vogel, Kelesitse Phiri, Nina Sahlertz Kristiansen, Andrea V. Margulis, Ingvild Odsbu, Kwame Appenteng, Cheryl Enger, Morten Olesen
المصدر: Phiri, K, Hallas, J, Linder, M, Margulis, A, Suehs, B, Arana, A, Bahmanyar, S, Hoffman, V, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Kristiansen, N S, Appenteng, K, de Vogel, S & Seeger, J 2021, ' A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder ', Current Medical Research and Opinion, vol. 37, no. 5, pp. 867-877 . https://doi.org/10.1080/03007995.2021.1891035Test
the Mirabegron PMR-PASS study group 2021, ' A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder ', Current Medical Research and Opinion . https://doi.org/10.1080/03007995.2021.1891035Testمصطلحات موضوعية: Male, medicine.medical_specialty, Urology, neoplasms, overactive, Muscarinic Antagonists, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, medicine, Humans, In patient, 030212 general & internal medicine, antimuscarinics, Urinary bladder, business.industry, Urinary Bladder, Overactive, Incidence (epidemiology), Cancer, General Medicine, medicine.disease, PASS, mirabegron, Thiazoles, medicine.anatomical_structure, Treatment Outcome, Urological Agents, Acetanilides, Female, Treatments for overactive bladder, Mirabegron, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e16fdb16219dfcf888757ab899a0540Test
https://pubmed.ncbi.nlm.nih.gov/33591859Test -
4
المؤلفون: Katarina Ivana Tudor, Juliana Ochulor, Mahreen Pakzad, Martina D. Liechti, Jai Seth, Jalesh N. Panicker, Collette Haslam, Gwen Gonzales, Zoe Fox
المصدر: Clinical Autonomic Research. 30:61-67
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Neurology, Urology, Neurological disorder, 030204 cardiovascular system & hematology, Transcutaneous electrical nerve stimulation, law.invention, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Lower urinary tract symptoms, law, medicine, Humans, Percutaneous tibial nerve stimulation, Aged, Retrospective Studies, Urinary Bladder, Overactive, Endocrine and Autonomic Systems, business.industry, Middle Aged, medicine.disease, Treatment Outcome, Urinary Incontinence, Overactive bladder, Transcutaneous Electric Nerve Stimulation, Female, Neurology (clinical), Tibial Nerve, Treatments for overactive bladder, business, 030217 neurology & neurosurgery
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d040d4d2ac9ab16f3ae5f6fd0a4d679Test
https://doi.org/10.1007/s10286-018-0553-8Test -
5
المؤلفون: Christopher P. Dall, Tatevik Broutian, Tasha Posid, Alicia Scimeca, Fara F. Bellows, Catherine Hudson, Kristin M. Ebert, Andrew F. Hundley, Ketul K. Shah, Matthew T. Harbrecht
المصدر: Canadian Urological Association Journal. 15
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urology, MEDLINE, medicine.disease, Patient counselling, Oncology, Overactive bladder, Chart review, Internal medicine, medicine, Multiple treatments, Initial treatment, Treatments for overactive bladder, business, Patient comfort
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::dadcf6db755a9d55ab4eb9c7d3996ec0Test
https://doi.org/10.5489/cuaj.6983Test -
6
المؤلفون: John D. Seeger, Stefan de Vogel, Andrea V. Margulis, Susana Perez Gutthann, Jesper Hallas, Kwame Appenteng, Brandon T. Suehs, Alejandro Arana, Morten S. Olesen, Nina Sahlertz Kristiansen, Cheryl Enger, Libby Horter, Veena Hoffman, Yihua Xu, Ingvild Odsbu, Marie Linder
المصدر: Circulation. 142
مصطلحات موضوعية: Agonist, medicine.medical_specialty, business.industry, medicine.drug_class, Placebo, medicine.disease, Clinical trial, Blood pressure, Physiology (medical), Internal medicine, medicine, Cardiology, Myocardial infarction, Treatments for overactive bladder, Cardiology and Cardiovascular Medicine, Mirabegron, business, Stroke, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1db0f2fc25a27e7aa2733f01192df96aTest
https://doi.org/10.1161/circ.142.suppl_3.13154Test -
7
المؤلفون: Zuha Imtiyaz, Mei Hsien Lee, Lih Lian Chen, Chin Hsien Chang, Chih Chun Ke, Hui I. Chen, Yuh-Chiang Shen
المصدر: Phytomedicine : international journal of phytotherapy and phytopharmacology. 80
مصطلحات موضوعية: Male, medicine.medical_specialty, Cinnamomum zeylanicum, Placebo-controlled study, Pharmaceutical Science, Placebo, law.invention, Placebos, 03 medical and health sciences, symbols.namesake, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Internal medicine, Drug Discovery, medicine, Clinical endpoint, Humans, Adverse effect, Fisher's exact test, 030304 developmental biology, Aged, Pharmacology, 0303 health sciences, business.industry, Urinary Bladder, Overactive, Middle Aged, medicine.disease, Treatment Outcome, Complementary and alternative medicine, Overactive bladder, 030220 oncology & carcinogenesis, symbols, Molecular Medicine, Female, Treatments for overactive bladder, business, Acupuncture Points
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec530830408ab4333ec5d90a65285efTest
https://pubmed.ncbi.nlm.nih.gov/33091856Test -
8
المؤلفون: Norifumi Sawada
المصدر: International journal of urology : official journal of the Japanese Urological AssociationReferences. 27(4)
مصطلحات موضوعية: medicine.medical_specialty, Urinary bladder, medicine.anatomical_structure, business.industry, Urinary Bladder, Overactive, Urology, MEDLINE, medicine, Humans, Treatments for overactive bladder, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276d991f3ce789c62c2a275c2939f1b2Test
https://pubmed.ncbi.nlm.nih.gov/32036621Test -
9
المؤلفون: Martin C. Michel
مصطلحات موضوعية: medicine.medical_specialty, Urinary Bladder, Overactive, business.industry, Urology, 030232 urology & nephrology, 610 Medizin, Efficacy expectations, Overactive bladder syndrome, Approved drug, Review article, 03 medical and health sciences, 0302 clinical medicine, Tolerability, Drug development, 030220 oncology & carcinogenesis, 610 Medical sciences, medicine, Animals, Humans, Biomarker (medicine), Treatments for overactive bladder, Intensive care medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac0691988ede2cb5f0d235e1cec4648Test
-
10
المؤلفون: Brigitte Schurch, Tom Marcelissen, Christopher H. Fry, Mario Averbeck, Arun Sahai, Sachin Malde, Alex Digesu
المصدر: Malde, S, Fry, C, Schurch, B, Marcelissen, T, Averbeck, M, Digesu, A & Sahai, A 2018, ' What is the exact working mechanism of botulinum toxin A and sacral neuromodulation in the treatment of overactive bladder / detrusor overactivity? ICI-RS 2017 ', Neurourology and Urodynamics, vol. 37, no. S4, pp. S108-S116 . https://doi.org/10.1002/nau.23552Test
مصطلحات موضوعية: 030232 urology & nephrology, urologic and male genital diseases, Botulinum toxin a, sacral neuromodulation, detrusor overactivity, 0302 clinical medicine, interstim, SPINAL-CORD-INJURY, Botulinum Toxins, Type A, Spinal cord injury, media_common, BLADDER UROTHELIAL CELLS, NEUROMODULATION, Botox, WOMEN, Botulinum toxin, female genital diseases and pregnancy complications, Neuromuscular Agents, Overactive bladder, INCONTINENCE, 030220 oncology & carcinogenesis, Treatments for overactive bladder, urodynamics, medicine.drug, medicine.medical_specialty, Urology, media_common.quotation_subject, Urination, Electric Stimulation Therapy, 03 medical and health sciences, NEUROGENIC DETRUSOR OVERACTIVITY, OnabotulinumtoxinA, medicine, Animals, Humans, botulinum toxin, Urothelium, INHIBITS ATP RELEASE, Urinary Bladder, Overactive, business.industry, LOWER URINARY-TRACT, medicine.disease, onabotulinumtoxinA, Sacral nerve stimulation, Interstim, overactive bladder, sacral nerve stimulation, Neurology (clinical), URGENCY, business, mechanism of action
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940359a102142cd644c9ed44b216611fTest
https://doi.org/10.1002/nau.23552Test
